Review of Hemoglobin‐Vesicles as Artificial Oxygen Carriers
- 23 January 2009
- journal article
- review article
- Published by Wiley in Artificial Organs
- Vol. 33 (2) , 139-145
Abstract
Blood transfusion systems have greatly benefited human health and welfare. Nevertheless, some problems remain: infection, blood type mismatching, immunological response, short shelf life, and screening test costs. Blood substitutes have been under development for decades to overcome such problems. Plasma component substitutes have already been established: plasma expanders, electrolytes, and recombinant coagulant factors. Herein, we focus on the development of red blood cell (RBC) substitutes. Side effects hindered early development of cell‐free hemoglobin (Hb)‐based oxygen carriers (HBOCs) and underscored the physiological importance of the cellular structure of RBCs. Well‐designed artificial oxygen carriers that meet requisite criteria are expected to be realized eventually. Encapsulation of Hb is one idea to shield the toxicities of molecular Hbs. However, intrinsic issues of encapsulated Hbs must be resolved: difficulties related to regulating the molecular assembly, and management of its physicochemical and biochemical properties. Hb‐vesicles (HbV) are a cellular type of HBOC that overcome these issues. The in vivo safety and efficacy of HbV have been studied extensively. The results illustrate the potential of HbV as a transfusion alternative and promise its use for other clinical applications that remain unattainable using RBC transfusion.Keywords
This publication has 22 references indexed in Scilit:
- Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and DeathJAMA, 2008
- Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemiaIntensive Care Medicine, 2008
- Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion BarrierJournal of Biological Chemistry, 2008
- Haemoglobin‐vesicles as artificial oxygen carriers: present situation and future visionsJournal of Internal Medicine, 2007
- Liposome-Encapsulated Hemoglobin Reduces the Size of Cerebral Infarction in the RatStroke, 2007
- Effects of Hemoglobin Vesicles, a Liposomal Artificial Oxygen Carrier, on Hematological Responses, Complement and Anaphylactic Reactions in RatsArtificial Cells, Blood Substitutes, and Biotechnology, 2007
- Review of Hemoglobin-Induced Myocardial LesionsArtificial Cells, Blood Substitutes, and Biotechnology, 2004
- Pulmonary Hypertension and Systemic Vasoconstriction May Offset the Benefits of Acellular Hemoglobin Blood SubstitutesThe Journal of Trauma: Injury, Infection, and Critical Care, 1997
- In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit.Proceedings of the National Academy of Sciences, 1991
- Synthesis and Evaluation of a Prototypal Artificial Red CellScience, 1985